ClinicalTrials.Veeva
Menu

Find clinical trials for Heart Disease in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Heart Diseases
Coronary Artery Disease
Cardiovascular Diseases
Heart Failure
Myocardial Ischemia
Coronary Disease
Hypertension

Heart Disease trials near Baltimore, MD, USA:

A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2 (Re-PHIRE)

is intended to assess the ability of AZD3427 to reduce pulmonary vascular resistance (PVR) after 24 weeks of treatment in participants with heart...

Enrolling
Heart Failure
Pulmonary Hypertension (World Health Organization Group 2)
Drug: AZD3427
Drug: Placebo

Phase 2

AstraZeneca
AstraZeneca

Baltimore, Maryland, United States and 63 other locations

Cardiac catheterization with invasive coronary angiography is the gold standard for determining the presence or absence of significant coronary heart...

Enrolling
Coronary Artery Disease
Diagnostic Test: CT angiography
Diagnostic Test: Invasive coronary angiography
Johns Hopkins University
Johns Hopkins University

Baltimore, Maryland, United States

The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treati...

Enrolling
Heart Valve Diseases
Aortic Valve Disease
Device: Navitor Transcatheter Aortic Valve Implantation (TAVI) System
Device: Any Commercially Available Transcatheter Aortic Valve (CAV) System
Abbott
Abbott

Washington, District of Columbia, United States and 20 other locations

To collect information about treatment for severe aortic stenosis (AS), which affects the aortic valve in the heart. Aortic stenosis is a na...

Active, not recruiting
Heart Valve Diseases
Cardiovascular Diseases
Device: JenaValve Pericardial TAVR System
JenaValve Technology

Washington, District of Columbia, United States and 12 other locations

This study is testing a potential new medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis.The study ...

Active, not recruiting
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Drug: NNC6019-0001
Drug: Placebo (NNC6019-0001)

Phase 2

Novo Nordisk
Novo Nordisk

Baltimore, Maryland, United States and 30 other locations

The utility of Ultra High-Resolution Computed Tomography (UHR-CT) compared to conventional CT in all-comers (i.e., a generally lower-risk population)...

Enrolling
Coronary Heart Disease (CHD)
Device: Conventional Computed Tomography
Device: Aquilion Precision
Johns Hopkins University
Johns Hopkins University

Baltimore, Maryland, United States

This study is comparing the use of Kcentra vs. standard transfusion in patients undergoing heart transplantation surgery. Half of the patien...

Enrolling
Heart Failure,Congestive
Heart Disease End Stage
Drug: Frozen Plasma Product, Human
Drug: Kcentra

Phase 3

Kathirvel Subramaniam

Baltimore, Maryland, United States and 2 other locations

Safety and performance evaluation of the preCARDIA System for patients with ADHF.

Enrolling
Acute Heart Failure
Acute Decompensated Heart Failure
Device: preCARDIA system
Abiomed
Abiomed

Washington, District of Columbia, United States and 16 other locations

The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Dr...

Enrolling
Transplant; Failure, Heart
Congenital Heart Disease
Device: EXCOR Active Driving System for Pediatric VAD
Berlin Heart

Washington, District of Columbia, United States and 10 other locations

This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...

Enrolling
Single Ventricle Heart Disease
Drug: Placebo
Drug: Udenafil

Phase 3

Mezzion Pharmaceuticals

Washington, District of Columbia, United States and 23 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems